Bausch Health Companies Inc. Stock
Heavy losses for Bausch Health Companies Inc. today as the stock fell by -€0.290 (-5.330%).
For the coming years our community has positive and negative things to say abot the Bausch Health Companies Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Bausch Health Companies Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bausch Health Companies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc. | -5.330% | 33.065% | 27.220% | 5.810% | -10.576% | -33.888% | -75.148% |
| Opko Health Inc. | 2.680% | -20.000% | -11.111% | 7.817% | 2.733% | -36.951% | -63.170% |
| Repligen Corp. | 1.890% | 11.210% | 12.439% | 37.194% | -2.449% | -11.923% | -36.212% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -5.172% | 0.917% | -45.813% | -55.645% |
Comments
Bausch Health Cos (NYSE:BHC) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Jefferies Financial Group Inc. from $13.00 to $9.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BHC provided by MarketBeat